UPDATED April 3, 2015, with comment from Radlink.
Johnson & Johnson‘s (NYSE:JNJ) DePuy Synthes subsidiary today said it signed an exclusive licensing deal for Radlink’s Galileo positioning system for use with DePuy’s line of hip replacement implants.
The Galileo system is designed to give surgeons real-time imaging and navigation data during hip replacement procedures, helping address component positioning, sizing, leg length and offset restoration for all surgical approaches, DePuy said.
"The GPS and Navio technologies are significant innovations that will help physicians deliver care as effectively and efficiently as possible," DePuy Synthes franchise leader Max Reinhardt said in prepared remarks. "We have chosen what we believe are among the best technologies in the marketplace that, when complemented by DePuy Synthes companies’ products, will provide a total solution and therefore maximize patient care."
DePuy said both Radlink’s Galileo and Blue Belt’s Navio are available in the U.S., "with launches planned in other geographies."
"Radlink’s breakthrough imaging technologies enable orthopedic surgeons to pre-operatively plan and intraoperatively confirm the placement of hip replacement implant components in a way that has not previously been possible," Radlink CEO Tom Hacking said in a statement.